SPECULATION STOCKS

[kiy]

Yield10 Bioscience (NASDAQ:YTEN) is now covered by analysts at Maxim Group. They set a "buy" rating and a $7.00 price target on the stock. 360.5% upside from the current price of $1.52.

https://www.americanbankingnews.com/2018/07/12/yield10-bioscience-yten-receives-new-coverage-from-analysts-at-maxim-group.html
Several institutional investors have recently modified their holdings of YTEN. Birchview Capital LP purchased a new position in shares of Yield10 Bioscience during the first quarter valued at about $807,000. Sabby Management LLC purchased a new position in shares of Yield10 Bioscience during the fourth quarter valued at about $381,000. Anson Funds Management LP purchased a new position in shares of Yield10 Bioscience during the fourth quarter valued at about $277,000. Renaissance Technologies LLC grew its position in shares of Yield10 Bioscience by 288.6% during the fourth quarter. Renaissance Technologies LLC now owns 79,576 shares of the specialty chemicals company’s stock valued at $141,000 after purchasing an additional 59,100 shares in the last quarter. Finally, GMT Capital Corp purchased a new position in shares of Yield10 Bioscience during the third quarter valued at about $107,000. Hedge funds and other institutional investors own 8.95% of the company’s stock.

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.